Fidelis Capital Partners’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.85M Buy
73,214
+8,899
+14% +$361K 0.2% 95
2025
Q4
$2.63M Buy
64,315
+13,256
+26% +$539K 0.19% 97
2025
Q3
$2.06M Buy
51,059
+1,116
+2% +$43K 0.16% 107
2025
Q2
$1.9M Buy
+49,943
New +$1.69M 0.17% 104

Other funds holding RECS

Fidelis Capital Partners's RECS Position: Q1 2026 in Review

Fidelis Capital Partners increased its Columbia Research Enhanced Core ETF (RECS) stake by 14% in Q1 2026, buying an estimated $361K and bringing the position to 73,214 shares worth $2.85M. The position accounts for 0.2% of the portfolio, ranked #95.

Fidelis Capital Partners first reported a position in RECS in Q2 2025 and has held it in 4 quarters since. 175 funds tracked by Wall St. Rank hold RECS as of Q1 2026.

  • Fidelis Capital Partners held 73,214 shares of Columbia Research Enhanced Core ETF worth $2.85M as of Q1 2026.
  • Fidelis Capital Partners bought 8,899 Columbia Research Enhanced Core ETF shares in Q1 2026, an estimated $361K.
  • Columbia Research Enhanced Core ETF made up 0.2% of Fidelis Capital Partners's portfolio in Q1 2026, its #95 holding.
  • Fidelis Capital Partners first reported a position in Columbia Research Enhanced Core ETF in Q2 2025 and has held it in 4 quarters since.
  • 175 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.